Rev Med UAS
Vol. 12: No. 3. Julio-Septiembre 2022
ISSN 2007-8013

COVID-19: Revisión de la evidencia científica sobre sus manifestaciones clínicas, diagnóstico, tratamiento y prevención

COVID-19: Review of the scientific evidence about clinical manifestations, diagnosis, treatment and prevention

Martha Martínez-Salazar1a, Karina Juárez-González2b, José Juan Castillo-Pérez3c, Salvador Vázquez-Vega4d*

  1. Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades “Dr. Bernardo Sepúlveda Gutiérrez”, Unidad de Investigación Médica en Inmunoquímica. Ciudad de México, México.
  2. Instituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 28, “Gabriel Mancera”, Medicina Familiar, Ciudad de México, México.
  3. Instituto Mexicano del Seguro Social, Coordinación de Investigación en Salud, División de Evaluación de la Investigación, Ciudad de México, México.
  4. Instituto Mexicano del Seguro Social. Unidad de Investigación Epidemiológica y en Servicios de Salud. Centro Médico Nacional Siglo XXI. Ciudad de México, México

ahttps://orcid.org/0000-0002-5650-596X

bhttps://orcid.org/0000-0002-4017-8562

chttps://orcid.org/0000-0002-3725-3541

dhttps://orcid.org/0000-0001-7544-0906

* Correspondencia: Salvador Vázquez-Vega
Teléfono: (55) 23139112. Correo electrónico: salvazvega@gmail.com

DOI http://dx.doi.org/10.28960/revmeduas.2007-8013.v12.n3.009

Texto Completo PDF

Recibido 08 de octubre 2021, aceptado 08 de diciembre 2021

RESUMEN
Nunca antes en la historia de la ciencia, se había generado tanta información en tiempo real sobre un fenómeno de salud, como con la COVID-19. La forma de evaluación, abordaje, diagnóstico, tratamiento, prevención y detección de secuelas de esta enfermedad, desde su aparición hasta la publicación de este trabajo, ha sido cambiante. Los profesionales de la salud han enfrentado uno de los mayores retos en su quehacer, sobre todo en países como el nuestro, donde los sistemas de salud muestran tantos problemas. La revisión que a continuación presentamos se elaboró a partir de la consulta de diferentes bases de datos bibliográficas: Pubmed, Medline, Scopus, Lilacs, Science direct, Scielo, Ovid y páginas oficiales de la OPS (Organización Panamericana de la Salud), y de la OMS (Organiza-ción Mundial de la Salud) para contribuir con evidencia científica sobre las manifestaciones clínicas, diagnóstico y prevención de la COVID-19, y coadyuvar en el quehacer clínico.
Palabras clave: SARS-CoV-2/COVID-19; Síntomas/signos; Respuesta inmune; Secuelas; Factores de riesgo; Vacunas; Nuevas tecnologías.

Abstract
Never before in the history of science has so much information been generated in real time on a health phenomenon as with COVID-19. The way of evaluating, approaching, diagnosing, treating, preventing and detecting the sequelae of this disease, from its appearance until the publication of this work, has been changing. Health professionals have faced one of the greatest challenges in their work, espe-cially in countries such as ours, where health systems show so many problems. The following review was elaborated from the consulta-tion of different bibliographic databases: Pubmed, Medline, Scopus, Lilacs, Science direct, Scielo, Ovid and official pages of PAHO (Pan American Health Organization) and WHO (World Health Organization) to contribute with scientific evidence on the clinical mani-festations, diagnosis and prevention of COVID-19, and to contribute to clinical practice.
Key words:SARS-CoV-2; COVID-19; Symptoms/signs; Immune response; Sequelae; Risk factors; Vaccines; New technologies.

REFERENCIAS

  1. Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Song Z-G, et al. A new coronavirus associated with human respiratory disease in China. Nature [Internet]. 2020 Mar;579(7798):265–9. Available from: http://dx.doi.org/10.1038/s41586-020-2008-3
  2. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature [Internet]. 2020 Mar;579(7798):270–3. Available from: http://dx.doi.org/10.1038/s41586-020-2012-7
  3. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med [Internet]. 2020 Feb 20;382(8):727–33. Available from: http://dx.doi.org/10.1056/NEJMoa2001017
  4. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet [Internet]. 2020 Feb 22;395(10224):565–74. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673620302518
  5. ¿Cuál es la diferencia entre brote, epidemia y pandemia? [Internet]. 2020 [cited 2021 Sep 6]. Available from: https://gacetamedica.com/investigacion/cual-es-la-diferencia-entre-brote-epidemia-y-pandemia/
  6. Gorbalenya AE, Enjuanes L, Ziebuhr J, Snijder EJ. Nidovirales: evolving the largest RNA virus genome. Virus Res [Internet]. 2006 Apr;117(1):17–37. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168170206000360
  7. Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, et al. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell [Internet]. 2020 Aug 20;182(4):812–27.e19. Available from: http://dx.doi.org/10.1016/j.cell.2020.06.043
  8. Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, et al. Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection. Clin Microbiol Rev [Internet]. 2021 Jun 16;34(3). Available from: http://dx.doi.org/10.1128/CMR.00228-20
  9. Pohl MO, Busnadiego I, Kufner V, Glas I, Karakus U, Schmutz S, et al. SARS-CoV-2 variants reveal features critical for replication in primary human cells. PLoS Biol [Internet]. 2021 Mar;19(3):e3001006. Available from: http://dx.doi.org/10.1371/journal.pbio.3001006
  10. Seguimiento de las variantes del SARS-CoV-2 [Internet]. [cited 2021 Sep 7]. Available from: https://www.who.int/es/activities/tracking-SARS-CoV-2-variants
  11. [No title] [Internet]. [cited 2021 Sep 7]. Available from: https://reliefweb.int/sites/reliefweb.int/files/resources/download_26.pdf
  12. Schön MP, Berking C, Biedermann T, Buhl T, Erpenbeck L, Eyerich K, et al. COVID-19 and immunological regulations - from basic and translational aspects to clinical implications. J Dtsch Dermatol Ges [Internet]. 2020 Aug;18(8):795–807. Available from: http://dx.doi.org/10.1111/ddg.14169
  13. Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of COVID-19 based on current evidence. J Med Virol [Internet]. 2020 Jun;92(6):548–51. Available from: http://dx.doi.org/10.1002/jmv.25722
  14. Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science [Internet]. 2020 May 1;368(6490):473–4. Available from: http://dx.doi.org/10.1126/science.abb8925
  15. Hannan MA, Rahman MA, Rahman MS, Sohag AAM, Dash R, Hossain KS, et al. Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response. Immunol Lett [Internet]. 2020 Oct;226:38–45. Available from: http://dx.doi.org/10.1016/j.imlet.2020.07.001
  16. Oliveira DS, Medeiros NI, Gomes JAS. Immune response in COVID-19: What do we currently know? Microb Pathog [Internet]. 2020 Nov;148:104484. Available from: http://dx.doi.org/10.1016/j.micpath.2020.104484
  17. Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst Rev [Internet]. 2021 Feb 23;2:CD013665. Available from: http://dx.doi.org/10.1002/14651858.CD013665.pub2
  18. Current diagnostic approaches to detect two important betacoronaviruses: Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Pathology - Research and Practice [Internet]. 2021 Sep 1 [cited 2021 Sep 7];225:153565. Available from: http://dx.doi.org/10.1016/j.prp.2021.153565
  19. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA [Internet]. 2020 May 12;323(18):1843–4. Available from: http://dx.doi.org/10.1001/jama.2020.3786
  20. Hemida MG. The next‐generation coronavirus diagnostic techniques with particular emphasis on the SARS‐CoV‐2 [Internet]. Vol. 93, Journal of Medical Virology. 2021. p. 4219–41. Available from: http://dx.doi.org/10.1002/jmv.26926
  21. Langa LS, Sallent LV, Díez SR. 167-173 10.1016/j.Fmc.2021.01.005 Langa Laura Soldevila LS programa de Salud internacional (PROSICS) metropolitana Norte, servicio de enfermedades infecciosas, hospital Universitari Germans Trias i Pujol. Sallent lluís Valerio LV programa de Salud internacional (PROSICS) metropolitana Norte, servicio de atención primaria, Badalona, Barcelona, España. Díez sílvia Roure SR programa de Salud internacional (PROSICS) metropolitana Norte, servicio de enfermedades infecciosas, hospital Universitari Germans Trias i Pujol. Spa journal article interpretación de las pruebas diagnósticas de la COVID-19. 2021 03 23. FMC - Form Médica Contin Aten Primaria [Internet]. 2021 Mar;28(3):167–73. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1134207221000220
  22. Preparedness E. Diagnostic testing for SARS-CoV-2 [Internet]. World Health Organization; 2020 [cited 2021 Sep 14]. Available from: https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2
  23. Brümmer LE, Katzenschlager S, Gaeddert M, Erdmann C, Schmitz S, Bota M, et al. Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis. PLoS Med [Internet]. 2021 Aug 12 [cited 2021 Sep 7];18(8):e1003735. Available from: https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003735&type=printable
  24. La Marca A, Capuzzo M, Paglia T, Roli L, Trenti T, Nelson SM. Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays. Reprod Biomed Online [Internet]. 2020 Sep;41(3):483–99. Available from: http://dx.doi.org/10.1016/j.rbmo.2020.06.001
  25. [No title] [Internet]. [cited 2021 Sep 7]. Available from: https://apps.who.int/iris/bitstream/handle/10665/338330/WHO-2019-nCoV-Surveillance_Case_Definition-2020.2-spa.pdf?sequence=1&isAllowed=y
  26. Machhi J, Herskovitz J, Senan AM, Dutta D, Nath B, Oleynikov MD, et al. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. J Neuroimmune Pharmacol [Internet]. 2020 Sep;15(3):359–86. Available from: http://dx.doi.org/10.1007/s11481-020-09944-5
  27. Izcovich A, Ragusa M, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, et al. Prognostic Factors for Severity and Mortality in Patients Infected with COVID-19: A Systematic Review. 2020 Jun 11 [cited 2021 Sep 7]; Available from: https://papers.ssrn.com/abstract=3627285
  28. Sisay T, Tolessa T. COVID-19 Pandemic: A Compressive Review on Gender, Herd Immunity, and Physiological Mechanisms. Risk Manag Healthc Policy [Internet]. 2020 Dec 14;13:2963–74. Available from: http://dx.doi.org/10.2147/RMHP.S276342
  29. Las infecciones fúngicas en la pandemia de COVID-19, el caso de la mucormicosis. Revista Argentina de Microbiología [Internet]. 2021 Jul 1 [cited 2021 Oct 4];53(3):181–2. Available from: http://dx.doi.org/10.1016/j.ram.2021.09.001
  30. Mahalaxmi I, Jayaramayya K, Venkatesan D, Subramaniam MD, Renu K, Vijayakumar P, et al. Mucormycosis: An opportunistic pathogen during COVID-19. Environ Res [Internet]. 2021 Oct;201:111643. Available from: http://dx.doi.org/10.1016/j.envres.2021.111643
  31. Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U, et al. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol [Internet]. 2021 Jul;69(7):1670–92. Available from: http://dx.doi.org/10.4103/ijo.IJO_1565_21
  32. Rodriguez-Morales AJ, Mamani-García CS, Nuñez-Lupaca JN, León-Figueroa DA, Olarte-Durand M, Yrene-Cubas RA, et al. COVID-19 and mucormycosis in Latin America - An emerging concern. Travel Med Infect Dis [Internet]. 2021 Aug 25;44:102156. Available from: http://dx.doi.org/10.1016/j.tmaid.2021.102156
  33. Wali AA, Abd-El-Fatah SM. Prognosis and Outcomes of COVID-19 infection During Pregnancy. In: Covid-19 Infections and Pregnancy [Internet]. Elsevier; 2021. p. 145–65. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780323905954000030
  34. Wastnedge EAN, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. Pregnancy and COVID-19. Physiol Rev [Internet]. 2021 Jan 1;101(1):303–18. Available from: http://dx.doi.org/10.1152/physrev.00024.2020
  35. Mirbeyk M, Saghazadeh A, Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates. Arch Gynecol Obstet [Internet]. 2021 Jul;304(1):5–38. Available from: http://dx.doi.org/10.1007/s00404-021-06049-z
  36. Di Mascio D, Buca D, Berghella V, Khalil A, Rizzo G, Odibo A, et al. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy. Ultrasound Obstet Gynecol [Internet]. 2021 May;57(5):687–97. Available from: http://dx.doi.org/10.1002/uog.23628
  37. Novoa RH, Quintana W, Llancarí P, Urbina-Quispe K, Guevara-Ríos E, Ventura W. Maternal clinical characteristics and perinatal outcomes among pregnant women with coronavirus disease 2019. A systematic review. Travel Med Infect Dis [Internet]. 2021 Jan;39:101919. Available from: http://dx.doi.org/10.1016/j.tmaid.2020.101919
  38. Siebach MK, Piedimonte G, Ley SH. COVID-19 in childhood: Transmission, clinical presentation, complications and risk factors. Pediatr Pulmonol [Internet]. 2021 Jun;56(6):1342–56. Available from: http://dx.doi.org/10.1002/ppul.25344
  39. Perikleous E, Tsalkidis A, Bush A, Paraskakis E. Coronavirus global pandemic: An overview of current findings among pediatric patients. Pediatr Pulmonol [Internet]. 2020 Dec;55(12):3252–67. Available from: http://dx.doi.org/10.1002/ppul.25087
  40. Oliva Marin JE. COVID-19 en niñez y adolescencia. Alerta [Internet]. 2021 Jan 14;4(1):48–60. Available from: https://www.lamjol.info/index.php/alerta/article/view/9780
  41. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv [Internet]. 2021 Jan 30; Available from: http://dx.doi.org/10.1101/2021.01.27.21250617
  42. Sharma A, Ahmad Farouk I, Lal SK. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses [Internet]. 2021 Jan 29;13(2). Available from: http://dx.doi.org/10.3390/v13020202
  43. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis [Internet]. 2021 Oct;53(10):737–54. Available from: http://dx.doi.org/10.1080/23744235.2021.1924397
  44. COVID-19 therapy: What weapons do we bring into battle? Bioorg Med Chem [Internet]. 2020 Dec 1 [cited 2021 Sep 8];28(23):115757. Available from: http://dx.doi.org/10.1016/j.bmc.2020.115757
  45. Website [Internet]. Available from: https://coronavirus.gob.mx/wp-content/uploads/2021/08/GuiaTx_COVID19_ConsensoInterinstitucional_2021.08.03
  46. Pormohammad A, Zarei M, Ghorbani S, Mohammadi M, Razizadeh MH, Turner DL, et al. Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Vaccines (Basel) [Internet]. 2021 May 6;9(5). Available from: http://dx.doi.org/10.3390/vaccines9050467
  47. Website [Internet]. Available from: https://coronavirus.gob.mx/wp-content/uploads/2021/03/GTApp_Cansino_16Mar2021.pdf
  48. Creech CB, Walker SC, Samuels RJ. SARS-CoV-2 Vaccines. JAMA [Internet]. 2021 Apr 6;325(13):1318–20. Available from: http://dx.doi.org/10.1001/jama.2021.3199